期刊文献+

羟基红花黄色素A对小鼠Lewis肺癌移植瘤的抑制作用 被引量:5

Anti-tumor Effect of Hydroxysafflor Yellow A on Transplanted Tumor of Lewis Lung Cancer Mice
下载PDF
导出
摘要 目的研究羟基红花黄色素A(hydroxysafflor yellow A,HSYA)对C57BL/6小鼠Lewis肺癌移植瘤的血管抑制作用。方法 C57BL/6近交系小鼠30只,造模后,分为5组,每组6只,分别使用生理盐水、环磷酰胺(CTX)及HSYA(分低、中、高3个剂量)作用于动物模型。观察各组肿瘤体积大小,分析小鼠生长曲线,并在造模第22天处死所有小鼠,无菌条件下剥取瘤组织进行HE染色,观察不同浓度HSYA在不同视野下对肿瘤血管的抑制情况。结果 HSYA中、小剂量组对小鼠移植瘤血管生成有一定抑制作用。结论中药羟基红花黄色素A(HSYA)对Lewis肺癌小鼠移植瘤血管生成有一定的抑制作用。 Objective To study the inhibitive effect of hydroxysafflor yellow A on transplanted tumor of Lewis lung cancer in C57BL/6 mice. Methods The model of C57BL/6 mice bearing Lewis lung cancer was established by subcutaneous seeding of Lewis lung cancer cells, and randomly divided into 5 groups (n = 6 ). Tumor-bearing mice were injected with normal saline, cyclophosphamide (CTX) or hydroxysafflor yellow A ( low, medium or high dose ) in each group. All mice were sacrificed on day 22nd under aseptic condition for the rumor collection. The transplanted tumors use hematoxylin-eosin staining. Different concentrations of hydroxysafflor yellow A inhibition of tumor blood vessels were observed. Results Small dose and medium dose hydroxysafflor yellow A can inhibit angiogenesis in transplanted tumor of mice. Conclusion Hydroxysafflor yellow A can inhibit tumor anglogenesis of Lewis hmg cancer in mice.
出处 《实用癌症杂志》 2016年第3期356-358,共3页 The Practical Journal of Cancer
基金 陕西省教育厅科学研究项目(编号:14JK1208)
关键词 羟基红花黄色素A Lewis肺癌移植瘤 血管生成 HE染色 Hydroxysafflor yellow A Transplanted tumor of Lewis lung cancer Angiogenesis Hematoxylin-eosin staining
  • 相关文献

参考文献4

二级参考文献20

  • 1张前,牛欣,闫妍,赵琰,金鸣,解华.羟基红花黄色素A对体外培养人脐静脉内皮细胞增殖的抑制作用[J].中国医药学报,2004,19(6):379-381. 被引量:30
  • 2王淑美,徐晓玉,陈刚,杨丽容.桃红四物汤Ⅱ号抑制小鼠B16黑色素瘤生长及VEGF,KDR/FLK-1表达[J].中国中药杂志,2005,30(23):1866-1869. 被引量:7
  • 3孙燕.临床肿瘤内科手册[M].4版.北京:人民卫生出版社,2003.
  • 4Miller KD,Sweeney CJ,Sledge GW.Redefining the target:chemotherapeutics as antiangiogenics[J].Clin Oncol,2001,19 (4):1195-1206.
  • 5Bertolini F,Paul S,Mancuso P,et al.Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells[J].Cancer Res,2003,63:4342 -4346.
  • 6Klement G,Huang P,Mayer B,et al.Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenografts[J].Clin Cancer Res,2002,8:221 -232.
  • 7Bocci G,Nicolaou KC,Kerbel RS.Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs[J].Cancer Res,2002,62:6938-6943.
  • 8Gilberta GC,Puglisi F,Azambuja E,et al.Angiogenesis and cancer:A cross-talk between basic science and clinical trials (the "do ut des" paradigm)[J].Crit Rev Oncol Hematol,2006,59(1):40 -50.
  • 9Shaked Y,Emmenegger U,Man S,et al.Optimal biologic dose of metronomic chemotherapy regimens is associated with maximum antiangiogenic activity[J].Blood,2005,106 (9):3058-3061.
  • 10朱华,冼丽萍,张玉萌,栗晓东,邹登峰.人胃癌裸鼠移植瘤转移模型的研究概况[J].科学技术与工程,2007,7(23):6031-6034. 被引量:4

共引文献46

同被引文献99

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部